Moriarty B. John's most recent trade in Avidity Biosciences Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | John Moriarty B. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Moriarty B. John | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 50,000 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | John B. Moriarty | EVP, Ch. Legal Officer & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | John B. Moriarty | EVP, CH. LEGAL OFFICER & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 166,250 | 166,250 | - | - | Stock Option (Right to Buy) |